Accelerate Enrollment and Retention to Deliver Faster Results
Traditional clinical trials are filled with barriers that slow enrollment, increase dropout rates, and burden trial sites with unnecessary administrative tasks. EVERSANA’s Specialty Pharmacy Programs eliminate these obstacles through direct-to-participant dispensing and continuous participant support—ensuring trials run more efficiently while improving patient accessibility and engagement.
- Direct-to-Participant Dispensing – Deliver trial medications straight to participants, eliminating unnecessary site visits and making trials more accessible.
- Higher Retention and Engagement – Keep participants on therapy with personalized support, digital tools, and seamless delivery.
- Reduced Site Burden – Free up clinical trial sites from administrative work, product storage and medication handling.
- Faster Data Collection & Trial Results – Get the insights you need sooner, accelerating your path to market.
EVERSANA Helps Manufacturers Transform Clinical Trials Through Direct-to-Participant Dispensing
A top pharmaceutical manufacturer partnered with EVERSANA to overcome the inefficiencies of traditional clinical trials such as burdensome in-person visits, administrative overload at trial sites and complex logistics.
These obstacles often delay progress and limit patient participation, but EVERSANA’s Direct-to-Participant (DTP) dispensing model helped this manufacturer modernize their process by delivering medications directly to participants’ homes or nearby locations, like FedEx drop points or retail pharmacies. Our patient-centered approach eased logistical challenges, expanded access and accelerated trial timelines.
Discover how EVERSANA helped this manufacturer transform their clinical trials by bringing therapies to patients faster—download the full case study below.